INXB

$15.86prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Chart populates over time

We just started tracking this portfolio. The line will fill in as the next 5-minute snapshot fires (or tonight after the US market close, whichever comes first).

Change+$0.00

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
INXBInhibrx Biosciences, Inc.	$15.86	+13.94%	$226M	—
CATBCatabasis Pharmaceuticals, Inc.	$8.54	-6.97%	$235M	—
CBLICytocom, Inc.	$3.17	-7.31%	$226M	—
CELUCelularity Inc.	$0.70	+0.06%	$20M	—
CRGXCARGO Therapeutics, Inc. Common Stock	$4.47	+0.00%	$216M	—
MACKMerrimack Pharmaceuticals, Inc.	$15.14	+0.10%	$224M	—
SLRNAcelyrin, Inc.	$2.27	+0.00%	$229M	—

Source: Financial Modeling Prep · peers by sector/industry

Held by traders on TradeandTell

No one on the platform currently holds INXB.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in INXB as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded INXB yet.